Advanced company searchLink opens in new window

GRITSTONE BIOPHARMACEUTICALS UK LTD

Company number 12631333

Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
31 May 2024 CS01 Confirmation statement made on 28 May 2024 with no updates
13 Feb 2024 AA Accounts for a dormant company made up to 31 May 2023
14 Jul 2023 AP01 Appointment of Vassiliki Economides as a director on 12 July 2023
10 Jul 2023 CS01 Confirmation statement made on 28 May 2023 with no updates
25 Jan 2023 AA Accounts for a dormant company made up to 31 May 2022
04 Oct 2022 TM01 Termination of appointment of Rahsaan Thompson as a director on 27 September 2022
31 May 2022 CS01 Confirmation statement made on 28 May 2022 with no updates
02 Mar 2022 AA Accounts for a dormant company made up to 31 May 2021
07 Jun 2021 CS01 Confirmation statement made on 28 May 2021 with updates
12 May 2021 PSC05 Change of details for Gritstone Oncology, Inc. as a person with significant control on 3 May 2021
02 Feb 2021 PSC02 Notification of Gritstone Oncology, Inc. as a person with significant control on 29 May 2020
02 Feb 2021 PSC09 Withdrawal of a person with significant control statement on 2 February 2021
04 Jan 2021 TM01 Termination of appointment of Jean-Marc Bellemin as a director on 11 December 2020
29 May 2020 NEWINC Incorporation
  • MODEL ARTICLES ‐ Model articles adopted (Amended Provisions)

Statement of capital on 2020-05-29
  • GBP 1